Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × Sunitinib × Clear all

NCT00581789 2019-11-19

Erlotinib and Sunitinib in NSCLC

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT00748163 2018-08-08

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01803503 2016-06-22

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Phase 2 Unknown

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Stomach Neoplasms

NCT00555256 2016-05-06

SU/Rapamycin

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT01402089 2016-02-02

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Phase 4 Completed

GastrointestinalGenitourinarySarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Gastrointestinal Stromal Tumors

NCT01210053 2010-09-28

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01019798 2009-11-25

Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung